Navigation Links
Commonwealth Biotechnologies 2011 Annual Shareholder Vote & Meeting Update Information
Date:3/29/2011

NEW HAVEN, Conn., March 29, 2011 /PRNewswire/ -- USChina Channel LLC announced today:

On March 11, 2011, Bill Guo, Chairman of Commonwealth Biotechnologies Inc. ("CBI") filed Form 8-k of SEC, to announce the detail of 2011 Annual Shareholder Vote & Meeting. The vote process is going very well.

We already have shareholders representing over 3 million shares of common stock made the vote. Followings are the interim vote results for the four proposals:PROPOSAL 001 ELECTION OF DIRECTOR: BILL GUOFOR

AGAINST

ABSTAIN

BROKER NONE-VOTESBENEFICIAL

366,658

21,848

0REGISTERED

2,615,693

0

0TOTAL SHARE VOTED

2,982,351

21,848

0% OF VOTED

99.27%

0.72%

0.00%% OF OUTSTANDING

24.66%

0.18%

0.00%PROPOSAL 002 REVISE OF ARTICLE OF CBI & ACCEPT MIN. 1 MEMBER OF DIRECTORS OF BOARDFOR

AGAINST

ABSTAIN

BROKER NONE-VOTESBENEFICIAL

365,658

22,848

0REGISTERED

2,615,693

0

0TOTAL SHARE VOTED

2,981,351

22,848

0% OF VOTED

99.23%

0.76%

0.00%% OF OUTSTANDING

24.65%

0.18%

0.00%PROPOSAL 003 REVISE OF BYLAWS OF CBI & ACCEPT MIN. 1 MEMBER OF DIRECTORS OF BOARDFOR

AGAINST

ABSTAIN

BROKER NONE-VOTESBENEFICIAL

365,658

22,848

0REGISTERED

2,615,693

0

0TOTAL SHARE VOTED

2,981,351

22,848

0% OF VOTED

99.23%

0.76%

0.00%% OF OUTSTANDING

24.65%

0.18%

0.00%PROPOSAL 004 SALARY & COMPES. OF NEW DIRECTOR WILL BE $1 PER YEARFOR

AGAINST

ABSTAIN

BROKER NONE-VOTESBENEFICIAL

388,206

300

0REGISTERED

2,615,693

0

0TOTAL SHARE VOTED

3,003,899

300

0% OF VOTED

99.99%

0.00%

0.00%% OF OUTSTANDING

24.83%

0.00%

0.00%There are 99.99% of the voted shares approved the proposal that the salary and compensation of new director(s) would be $1 per year. To cut the overhead expenses sharply became the whelming demands of the voted shareholders.

These shareholders, who haven't voted, could go to www.proxyvote.com making a vote now. Whether you agree or disagree, your voice is important for CBI which is in a critical status for fighting surviving.

We welcome all shareholders to attend the CBI 2011 Annual Shareholders Meeting, which will be held at 10:00 a.m. EDT, on April 4, 2011. The meeting will be held electronically via telecom.  Here is the url address that has been assigned for your virtual annual meeting: 

http://www.virtualshareholdermeeting.com/CBTE

Shareholders will be able to log onto the above site approximately 15 minutes prior to the meeting to listen to the proceedings, view the annual meeting materials, vote their shares and ask a question if they choose to do so. 

Since we suspended SEC reporting status, shareholders could go to the url address www.otcmarkets.com from CBI trading symbol or name to find the limited communication between company and public.

If you have any question, please contact:

Bill Guo  Address: Venturepharm Towers

USA: C/o Agent: Andrew ChienNo. 3 Jinzhuang, Sijiqing, Haidian District

665 Ellsworth AvenueBeijing, China PC 100089

 New Haven, CT 06511Tel: 86-10-88500088

Tel: 203-8440809Fax: 86-10-88500080

Fax: 8665716313E-mail: la@venturepharm.com

E-mail: uschien@uschinachannel.netWe hired InvestorCom, Inc to do proxy solicitation, and any one could contact them by:

John Glenn Grau, President.  InvestorCom, Inc., www.investor-com.com65 Locust Avenue, Third Floor,  New Canaan, CT   06840P (203) 972-9300 ext. 11   F (203) 966-6478
M (646) 242-041045 Park Avenue, Suite 3900, New York, NY
7P (212) 668-0800
'/>"/>

SOURCE Commonwealth Biotechnologies Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Commonwealth Biotechnologies Presents Data at Forensic Sciences Meeting Confirming Benefits of ZyGEMs DNA Extraction Technology
2. Commonwealth Care Alliance Selects Casenet To Unify Patient Information and Improve Care for Massachusetts Members
3. Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies
4. Epeius Biotechnologies REXIN-G, a Tumor-Targeted Genetic Medicine for Metastatic Cancer, Gains Phase 3 Product Designation From the U.S. FDA
5. Reportlinker Adds Nanobiotechnologies- applications, markets and companies
6. TriLink BioTechnologies Launches CleanAmp™ 7-deaza-dGTP for GC-rich Target Amplification
7. Maven Biotechnologies Receives $1.96 Million From the National Institutes of Health (NIH) to Develop Their LFIRE™ Label-Free Detection Technology for Proteomics
8. Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies
9. TriLink BioTechnologies to Sponsor Take Me Out to the Ballgame, a SAY San Diego Event Benefiting San Diego Families in Need
10. Novel Stem Cell Therapy From Cellonis Biotechnologies Can Help Children With Diabetes Get Back Their Normal Lives
11. Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... 2017 , ... DaVita Clinical Research (DCR), a ... device development, and Prism Clinical Research , a leader in providing fully ... Clinical Trials (VCT) has been selected by both companies as an exclusive ...
(Date:1/19/2017)... , Jan. 18, 2017  Northwest Biotherapeutics, Inc. (OTCQB: ... personalized immune therapies for operable and inoperable solid tumor ... Chief Technical Officer of NW Bio, will present at ... 2017, at the Hyatt Regency Hotel in ... chair the session entitled "New Therapeutic Approaches – Expanding ...
(Date:1/19/2017)... , Jan. 18, 2017 BD (Becton, Dickinson and ... announced today that it will host a live webcast of its ... p.m. (ET). The webcast can be accessed from ... for replay through Tuesday, January 31, 2017. ... About BD BD is a ...
(Date:1/18/2017)... -- According to a new market research report "In situ Hybridization ... End User (Molecular Diagnostic Laboratories, Academic and Research Institutions) - Global Forecast to ... by 2021 from USD 557.1 Million in 2016, growing at a CAGR of ... ... MarketsandMarkets Logo ...
Breaking Biology Technology:
(Date:1/6/2017)...  Delta ID Inc., a leader in consumer-grade iris ... at CES® 2017. Delta ID has collaborated with Gentex ... use of iris scanning as a secure, reliable and ... a car, and as a way to elevate the ... Delta ID and Gentex will demonstrate (booth #7326 LVCC) ...
(Date:1/4/2017)... LAS VEGAS , Jan. 4, 2017 /PRNewswire/ ... in performance biometric sensor technology, today announced the ... Benchmark™ sensor systems, the highly-accurate biometric sensor ... ® biometric technology, experience and expertise. The ... of Benchmark designed specifically for hearables, and Benchmark ...
(Date:12/22/2016)... Dec. 20, 2016  As part of its longstanding mission ... personal genetics company, recently released its latest children,s book, titled ... book focuses on the topics of inheritance and variation of ... (NGSS) taught in elementary school classrooms in the US. ... by illustrator Ariana Killoran , whose previous book with ...
Breaking Biology News(10 mins):